Effects of Structural Integration on Chest Wall Expansion Among COPD Patients

NCT07752420 | Not Yet Recruiting DMC

• 1 other identifier: GIU/IRB/110047-1
• Study Type: interventional
• Target: 52
• Locations: 1 country
• Sites: 1

Brief Summary

The present study aims to investigate the effects of the 10-Series of Structural Integration on chest wall expansion in patients with stable COPD using a randomized controlled trial design. Participants receiving Structural Integration in addition to conventional pulmonary rehabilitation will be compared with those receiving conventional pulmonary rehabilitation alone. Chest wall expansion will serve as the primary outcome, while pulmonary function, dyspnea, functional exercise capacity, and quality of life may be evaluated as secondary outcomes.

Conditions

COPD (With - Without Rehabilitation)

Keywords

COPD; Structural Integration; Chest Wall Expansion; Pulmonary Rehabilitation

Outcome Measures

Primary Outcomes (1)

• Chest Wall Expansion

  Chest wall expansion will be measured using a flexible measuring tape at: * Axillary level * Xiphoid level * Lower thoracic level (10th rib) Measurements will be taken during maximal inspiration and maximal expiration. The difference (in centimeters) will be recorded. Three readings will be obtained at each level, and the average value will be used for analysis.

  Before the start and end of 10 weeks

Study Arms (2)

Experimental Group

EXPERIMENTAL

Other: Structural Integration with Conventional Pulmonary Rehabilitation

Control Group

ACTIVE COMPARATOR

Other: Pulmonary Rehabilitation only

Interventions

Structural Integration with Conventional Pulmonary Rehabilitation OTHER

* Conventional pulmonary rehabilitation. * The complete 10-Series of Structural Integration, delivered by a certified Structural Integration practitioner/physiotherapist.

Experimental Group

Pulmonary Rehabilitation only OTHER

Participants receive only the conventional pulmonary rehabilitation program.

Control Group

Eligibility Criteria

• Age: 50 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Clinically diagnosed stable COPD according to GOLD criteria
• GOLD stage II or III
• No acute exacerbation within the previous four weeks
• Able to ambulate independently
• Medically cleared to participate in pulmonary rehabilitation
• Willing to provide written informed consent

You may not qualify if:

• Severe cardiovascular disease contraindicating exercise
• Recent thoracic or abdominal surgery (\<6 months)
• Rib fractures or severe chest wall deformity
• Neurological disorders affecting mobility
• Active malignancy
• Severe osteoporosis with high fracture risk
• Previous Structural Integration treatment within the last year

Sponsors & Collaborators

• Green International University: lead

Study Sites (1)

Ali Fatima Hospital

Lahore, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Mohtishim Ahmed, MSPT, DPT

CONTACT

+923224057371; mohtishim.ahmed@giu.edu.pk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: August 4, 2026
• First Posted: August 7, 2026
• Study Start (Estimated): September 1, 2026
• Primary Completion (Estimated): November 15, 2026
• Study Completion (Estimated): December 30, 2026
• Last Updated: August 7, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, CSR

Locations

PA (1)